Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02382783 · ClinicalTrials.gov registry record · NA

Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA)

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
178
Enrollment target

NCT02382783: Completed NA study, sponsored by Mayo Clinic.

NCT02382783 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 178 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02382783, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
178 participants
Enrollment target

Study Summary

The purpose of this study is to determine how best to monitor for flares in patients with rheumatoid arthritis (RA).

Primary Outcome

The occurrence of flares over the follow-up time (flare rate). The Outcome Measures in Rheumatology(OMERACT-9) definition of flare will be applied to both groups to determine how many occurrences indicate worsening of disease activity, leading to initiation, change, or increase of therapy by RHCPs. This definition will allow for parallel comparisons of flare rates in both groups.

Interventions

  • OTHER FLARE Intervention Group

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2015-03
Est. Completion 2020-07-01
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT02382783 record still lists

NCT02382783 is an interventional study that assigns participants to a tested intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).

The record links to 0 conditions, and to 1 intervention - of which FLARE Intervention Group is the first listed.

NCT02382783 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02382783 about?

NCT02382783 is a clinical study titled "Optimizing the Management of Flares in Patients With Rheumatoid Arthritis (RA)". The purpose of this study is to determine how best to monitor for flares in patients with rheumatoid arthritis (RA).

What is the current status of trial NCT02382783?

This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2015-03. Estimated completion is 2020-07-01.

What interventions are being tested in trial NCT02382783?

The interventions under investigation include: FLARE Intervention Group (OTHER).

Who is sponsoring clinical trial NCT02382783?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02382783's enrollment target sits among peer trials

178 604th of 2000 higher than 1,397 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03642002 · 178 participants · NA

    The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU

  • NCT04227847 · 178 participants · Phase 1

    A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

  • NCT04855214 · 178 participants

    Evaluating the Experience of Upper Limb Prosthesis Use

  • NCT05391126 · 178 participants · NA

    GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02382783, the US trial registry maintained by the National Library of Medicine. NCT02382783 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.